These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11797317)

  • 1. Enhancement of scleral macromolecular permeability with prostaglandins.
    Weinreb RN
    Trans Am Ophthalmol Soc; 2001; 99():319-43. PubMed ID: 11797317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased human scleral permeability with prostaglandin exposure.
    Kim JW; Lindsey JD; Wang N; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1514-21. PubMed ID: 11381055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
    Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced FGF-2 movement through human sclera after exposure to latanoprost.
    Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2554-9. PubMed ID: 11581197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of prostaglandin EP(1), EP(2), and FP receptor subtypes in human sclera.
    Anthony TL; Lindsey JD; Aihara M; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3182-6. PubMed ID: 11726620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.
    Sagara T; Gaton DD; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
    Arch Ophthalmol; 1999 Jun; 117(6):794-801. PubMed ID: 10369592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.
    Wang N; Lindsey JD; Angert M; Weinreb RN
    Curr Eye Res; 2001 Mar; 22(3):198-207. PubMed ID: 11462156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment.
    Gaton DD; Sagara T; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
    Arch Ophthalmol; 2001 Aug; 119(8):1165-70. PubMed ID: 11483084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of prostaglandin F receptor in scleral and subconjunctival tissue.
    Imai K; Ueta M; Mori K; Ueno M; Ikeda Y; Oga T; Yokoi N; Shinomiya K; Narumiya S; Kinoshita S
    Br J Ophthalmol; 2012 Aug; 96(8):1148-9. PubMed ID: 22581279
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct matrix metalloproteinase enhancement of transscleral permeability.
    Lindsey JD; Crowston JG; Tran A; Morris C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):752-5. PubMed ID: 17251474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin F2 alpha receptors in the human trabecular meshwork.
    Anthony TL; Pierce KL; Stamer WD; Regan JW
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):315-21. PubMed ID: 9477988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
    Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
    Yousufzai SY; Ye Z; Abdel-Latif AA
    Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
    el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of prostaglandin receptors EP4 and FP in human lens epithelial cells.
    Mukhopadhyay P; Bhattacherjee P; Andom T; Geoghegan TE; Andley UP; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):105-12. PubMed ID: 9888433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells.
    Lindsey JD; Kashiwagi K; Boyle D; Kashiwagi F; Firestein GS; Weinreb RN
    Curr Eye Res; 1996 Aug; 15(8):869-75. PubMed ID: 8921230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latanoprost eye drops increase concentration of glycosaminoglycans in posterior rabbit sclera.
    Trier K; Ribel-Madsen SM
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):185-8. PubMed ID: 15279723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of collagen-binding integrin receptors in the mammalian sclera and their regulation during the development of myopia.
    McBrien NA; Metlapally R; Jobling AI; Gentle A
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4674-82. PubMed ID: 17065473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.